Enzymatically Transformable Polymersome-Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer.
Li J, Ge Z, Toh K, Liu X, Dirisala A, Ke W, Wen P, Zhou H, Wang Z, Xiao S, Van Guyse JFR, Tockary TA, Xie J, Gonzalez-Carter D, Kinoh H, Uchida S, Anraku Y, Kataoka K.
Li J, et al. Among authors: xie j.
Adv Mater. 2021 Dec;33(49):e2105254. doi: 10.1002/adma.202105254. Epub 2021 Oct 7.
Adv Mater. 2021.
PMID: 34622509